References
- Turk V, Turk B, Turk D. Lysosomal cysteine proteases: facts and opportunities. EMBO J 2001; 20: 4629-33.
- Kirschke H. Cathepsin H. In: Barret AJ, Rawlings ND, Woessner JF. Handbook of proteolytic enzymes. 2nd edition. London: Elsevier Academic Press; 2004. p. 1089-92.
- Kirschke H, Barrett AJ, Rawlings ND. Lysosomal cysteine proteases. 2nd edition. Oxford: Oxford University Press; 1998.
- Ritonja A, Popovic T, Kotnik M, Machleidt W, Turk V. Amino acid sequences of the human kidney cathepsins H and L. FEBS Lett 1988; 228: 341-5.
- Vasiljeva O, Dolinar M, Turk V, Turk B. Recombinant human cathepsin H lacking the mini chain is an endopeptidase. Biochemistry 2003; 42: 13522-8.
- Nishimura Y, Kato K. Identification of latent procathepsin H in microsomal lumen: characterization of proteolytic processing and enzyme activation. Arch Biochem Biophys 1988; 260: 712-8.
- Kominami E, Tsukahara T, Hara K, Katunuma N. Biosyntheses and processing of lysosomal cysteine proteinases in rat macrophages. FEBS Lett 1988; 231: 225-8.
- Gocheva V, Chen X, Peters C, Reinheckel T, Joyce JA. Deletion of cathepsin H perturbs angiogenic switching, vascularization and growth of tumors in a mouse model of pancreatic islet cell cancer. Biol Chem 2010; 391: 937-45.
- Wu SM, Huang YH, Yeh CT, Tsai MM, Liao CH, Cheng WL, et al. Cathepsin H regulated by the thyroid hormone receptors associate with tumor invasion in human hepatoma cells. Oncogene 2011; 30: 2057-69.
- Ciric E, Sersa G. Radiotherapy in combination with vascular-targeted therapies. Radiol Oncol 2010; 44: 67-78.
- Gabrijelcic D, Svetic B, Spaic D, Skrk J, Budihna M, Dolenc I, et al. Cathepsins B, H and L in human breast carcinoma. Eur J Clin Chem Clin Biochem 1992; 30: 69-74.
- Schweiger A, Christensen IJ, Nielsen HJ, Sørensen S, Brünner N, Kos J. Serum cathepsin H as a potential prognostic marker in patients with colorectal cancer. Int J Biol Markers 2004; 19: 289-94.
- Kos J, Stabuc B, Schweiger A, Krasovec M, Cimerman N, Kopitar-Jerala N, et al. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin Cancer Res 1997; 3: 1815-22.
- Budihna M, Strojan P, Smid L, Skrk J, Vrhovec I, Zupevc A, et al. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma. Biol Chem Hoppe Seyler 1996; 377: 385-90.
- Strojan P. Cysteine cathepsins and stefins in head and neck cancer: an update of clinical studies. Radiol Oncol 2008; 42: 69-81.
- Sivaparvathi M, Sawaya R, Gokaslan ZL, Chintala SK, Rao JS. Expression and the role of cathepsin H in human glioma progression and invasion. Cancer Lett 1996; 104: 121-6.
- Friedrich B, Jung K, Lein M, Türk I, Rudolph B, Hampel G, et al. Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue. Eur J Cancer 1999; 35: 138-44.
- Schweiger A, Staib A, Werle B, Krasovec M, Lah TT, Ebert W, et al. Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking. Br J Cancer 2000; 82: 782-8.
- Ueno T, Linder S, Na CL, Rice WR, Johansson J, Weaver TE. Processing of pulmonary surfactant protein B by napsin and cathepsin H. J Biol Chem 2004; 279: 16178-84.
- Serveau-Avesque C, Martino MF, Hervé-Grépinet V, Hazouard E, Gauthier F, Diot E, et al. Active cathepsins B, H, K, L and S in human inflammatory bronchoalveolar lavage fluids. Biol Cell 2006; 98: 15-22.
- Brasch F, Ten Brinke A, Johnen G, Ochs M, Kapp N, Müller KM, et al. Involvement of cathepsin H in the processing of the hydrophobic surfactantassociated protein C in type II pneumocytes. Am J Respir Cell Mol Biol 2002; 26: 659-70.
- D'Angelo ME, Bird PI, Peters C, Reinheckel T, Trapani JA, Sutton VR. Cathepsin H is an additional convertase of pro-granzyme B. J Biol Chem 2010; 285: 20514-9.
- Lü J, Qian J, Keppler D, Cardoso WV. Cathespin H is an Fgf10 target involved in Bmp4 degradation during lung branching morphogenesis. J Biol Chem 2007; 282: 22176-84.
- Hogan BL. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996; 10: 1580-94.
- Deng H, Ravikumar TS, Yang WL. Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells. Cancer Lett 2009; 281: 220-31.
- Maegdefrau U, Amann T, Winklmeier A, Braig S, Schubert T, Weiss TS, et al. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression. J Pathol 2009; 218: 520-9.
- Cui Y, Jean F, Thomas G, Christian JL. BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development. EMBO J 1998; 17: 4735-43.
- Degnin C, Jean F, Thomas G, Christian JL. Cleavages within the prodomain direct intracellular trafficking and degradation of mature bone morphogenetic protein-4. Mol Biol Cell 2004; 15: 5012-20.
- Goldman DC, Hackenmiller R, Nakayama T, Sopory S, Wong C, Kulessa H, et al. Mutation of an upstream cleavage site in the BMP4 prodomain leads to tissue-specific loss of activity. Development 2006; 133: 1933-42.
- Schweiger A, Stabuc B, Popovíc T, Turk V, Kos J. Enzyme-linked immunosorbent assay for the detection of total cathepsin H in human tissue cytosols and sera. J Immunol Methods 1997; 201: 165-72.
- Jevnikar Z, Obermajer N, Bogyo M, Kos J. The role of cathepsin X in the migration and invasiveness of T lymphocytes. J Cell Sci 2008; 121: 2652-61.
- Angliker H, Wikstrom P, Kirschke H, Shaw E. The inactivation of the cysteinyl exopeptidases cathepsin H and C by affinity-labelling reagents. Biochem J 1989; 262: 63-8.
- Obermajer N, Svajger U, Bogyo M, Jeras M, Kos J. Maturation of dendritic cells depends on proteolytic cleavage by cathepsin X. J Leukoc Biol 2008; 84: 1306-15.
- Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004; 22: 233-41.
- Kominami E, Tsukahara T, Bando Y, Katunuma N. Distribution of cathepsins B and H in rat tissues and peripheral blood cells. J Biochem 1985; 98: 87-93.
- del Re EC, Shuja S, Cai J, Murnane MJ. Alterations in cathepsin H activity and protein patterns in human colorectal carcinomas. Br J Cancer 2000; 82: 1317-26.
- Waghray A, Keppler D, Sloane BF, Schuger L, Chen YQ. Analysis of a truncated form of cathepsin H in human prostate tumor cells. J Biol Chem 2002; 277: 11533-8.
- Cui Y, Hackenmiller R, Berg L, Jean F, Nakayama T, Thomas G, et al. The activity and signaling range of mature BMP-4 is regulated by sequential cleavage at two sites within the prodomain of the precursor. Genes Dev 2001; 15: 2797-802.
- Takahashi T, Dehdarani AH, Tang J. Porcine spleen cathepsin H hydrolyzes oligopeptides solely by aminopeptidase activity. J Biol Chem 1988; 263: 10952-7.
- Ohkawara B, Iemura S, ten Dijke P, Ueno N. Action range of BMP is defined by its N-terminal basic amino acid core. Curr Biol 2002; 12: 205-9.
- Zhou Z, Sun L, Wang Y, Wu Z, Geng J, Miu W, et al. Bone morphogenetic protein 4 inhibits cell proliferation and induces apoptosis in glioma stem cells. Cancer Biother Radiopharm 2011; 26: 77-83.
- Lombardo Y, Scopelliti A, Cammareri P, Todaro M, Iovino F, Ricci-Vitiani L, et al. Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. Gastroenterology 2011; 140: 297-309.
- Goldman DC, Bailey AS, Pfaffle DL, Al Masri A, Christian JL, Fleming WH. BMP4 regulates the hematopoietic stem cell niche. Blood 2009; 114: 4393-401.
- Ardebili SY, Zajc I, Gole B, Campos B, Herold-Mende C, Drmota S, Lah TT. CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsins' expression in glioblastoma derived spheroids. Radiol Oncol 2011; 45: 102-15.